NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 cli…

Biotechnology

US, Boston [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

H1B/PERM Strategy
Macro
News
Peers Performance
Clinical Trials [Soon]
Industry H&T [Soon]
Patents / Trademarks [Soon]
Relevant Disputes [Soon]

Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

Similar Stocks · Adjusted Close

A quick analysis that compared NeuroBo Pharmaceuticals, Inc. (NRBO) to it's peer group.

Peer Group

BWV PHIO KPRX HILS PXMD ZURA KRBP CDIO ALLR QNRX REVB SONN ATNF Compare Together